Comparison of antifungal MICs for yeasts obtained using the EUCAST method in a reference laboratory and the Etest in nine different hospital laboratories

Clinical Microbiology and Infection

Volumn 16, Issue 7, 2010, Pages 863-869

  Dannaoui, E ^a   Paugam, A ^a   Develoux, M ^b   Chochillon, C ^b   Matheron, J ^c   Datry, A ^a   Bouges Michel, C ^d   Bonnal, C ^e   Dromer, F ^f   Bretagne, S ^g  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b HÔPITAL SAINT ANTOINE   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d AVICENNE HOSPITAL   (France)

^e BICÊTRE HOSPITAL   (France)

^f INSTITUT PASTEUR   (France)

^g FACULTÉ DE MÉDECINE   (France)

Author keywords

Antimicrobial testing; Etest; EUCAST; MIC; Mycology

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; CASPOFUNGIN; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE; VORICONAZOLE;

ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; BLOOD CULTURE; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CRYPTOCOCCUS NEOFORMANS; DILUTION; EPSILOMETER TEST; EUROPEAN COMMITTEE ON ANTIBIOTIC SUSCEPTIBILITY TESTING; FUNGEMIA; FUNGUS ISOLATION; IN VITRO STUDY; LABORATORY TEST; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; FILOBASIDIELLA NEOFORMANS;

EID: 77954654633     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2009.02997.x     Document Type: Article

References (30)

1. Ruhnke M. Epidemiology of Candida albicans infections and role of non-Candida albicans yeasts. Curr Drug Targets 2006, 7:495-504.
2. Nucci M, Marr KA. Emerging fungal diseases. Clin Infect Dis 2005, 41:521-526.
3. Masia Canuto M, Gutierrez Rodero F. Antifungal drug resistance to azoles and polyenes. Lancet Infect Dis 2002, 2:550-563.
4. Sanglard D, Odds FC. Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences. Lancet Infect Dis 2002, 2:73-85.
5. Arikan S. Current status of antifungal susceptibility testing methods. Med Mycol 2007, 45:569-587.
6. Johnson EM. Issues in antifungal susceptibility testing. J Antimicrob Chemother 2008, 61(suppl 1):i13-i18.
7. Reference method for broth dilution antifungal susceptibility testing of yeasts. M-27a2 2002, Wayne, PA, CLSI
8. EUCAST definitive document 7.1: method for the determination of broth dilution MICs of antifungal agents for fermentative yeasts. Clin Microbiol Infect 2008, 14:398-405.
9. Chryssanthou E, Cuenca-Estrella M. Comparison of the antifungal susceptibility testing subcommittee of the European Committee on Antibiotic Susceptibility Testing proposed standard and the E-test with the NCCLS broth microdilution method for voriconazole and caspofungin susceptibility testing of yeast species. J Clin Microbiol 2002, 40:3841-3844.
10. Cuenca-Estrella M, Lee-Yang W, Ciblak MA. Comparative evaluation of NCCLS M27-A and EUCAST broth microdilution procedures for antifungal susceptibility testing of Candida species. Antimicrob Agents Chemother 2002, 46:3644-3647.
11. Cuenca-Estrella M, Gomez-Lopez A, Mellado E, Rodriguez-Tudela JL. Correlation between the procedure for antifungal susceptibility testing for Candida spp. of the European Committee on Antibiotic Susceptibility Testing (EUCAST) and four commercial techniques. Clin Microbiol Infect 2005, 11:486-492.
12. Morace G, Amato G, Bistoni F. Multicenter comparative evaluation of six commercial systems and the National Committee for Clinical Laboratory Standards M27-A broth microdilution method for fluconazole susceptibility testing of Candida species. J Clin Microbiol 2002, 40:2953-2958.
13. Chryssanthou E. Trends in antifungal susceptibility among Swedish Candida species bloodstream isolates from 1994 to 1998: comparison of the E-test and the Sensititre YeastOne colorimetric antifungal panel with the NCCLS M27-A reference method. J Clin Microbiol 2001, 39:4181-4183.
14. Fleck R, Dietz A, Hof H. In vitro susceptibility of Candida species to five antifungal agents in a German university hospital assessed by the reference broth microdilution method and Etest. J Antimicrob Chemother 2007, 59:767-771.
15. Matsumoto FE, Dias AL, Melhem MS. Antifungal susceptibility of bloodstream yeasts isolated at a public children's hospital in Brazil: comparison of the Etest and the AFST-EUCAST microdilution method. Can J Microbiol 2007, 53:1300-1306.
16. Pfaller MA, Messer SA, Bolmstrom A, Odds FC, Rex JH. Multisite reproducibility of the Etest MIC method for antifungal susceptibility testing of yeast isolates. J Clin Microbiol 1996, 34:1691-1693.
17. Espinel-Ingroff A, Pfaller M, Erwin ME, Jones RN. Interlaboratory evaluation of Etest method for testing antifungal susceptibilities of pathogenic yeasts to five antifungal agents by using casitone agar and solidified RPMI 1640 medium with 2% glucose. J Clin Microbiol 1996, 34:848-852.
18. Donnelly SM, Sullivan DJ, Shanley DB, Coleman DC. Phylogenetic analysis and rapid identification of Candida dubliniensis based on analysis of ACT1 intron and exon sequences. Microbiology 1999, 8:1871-1882.
19. EUCAST technical note on fluconazole. Clin Microbiol Infect 2008, 14:193-195.
20. EUCAST technical note on voriconazole. Clin Microbiol Infect 2008, 14:985-987.
21. Desnos-Ollivier M, Bretagne S, Raoux D, Hoinard D, Dromer F, Dannaoui E. Mutations in the fks1 gene in Candida albicans, C. tropicalis, and C. krusei correlate with elevated caspofungin MICs uncovered in AM3 medium using the method of the European Committee on Antibiotic Susceptibility Testing. Antimicrob Agents Chemother 2008, 52:3092-3098.
22. Desnos-Ollivier M, Dromer F, Dannaoui E. Detection of caspofungin resistance in Candida spp. by Etest. J Clin Microbiol 2008, 46:2389-2392.
23. Cuenca-Estrella M, Arendrup MC, Chryssanthou E. Multicentre determination of quality control strains and quality control ranges for antifungal susceptibility testing of yeasts and filamentous fungi using the methods of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antimicrobial Susceptibility Testing (AFST-EUCAST). Clin Microbiol Infect 2007, 13:1018-1022.
24. Kanafani ZA, Perfect JR. Antimicrobial resistance: resistance to antifungal agents: mechanisms and clinical impact. Clin Infect Dis 2008, 46:120-128.
25. Krogh-Madsen M, Arendrup MC, Heslet L, Knudsen JD. Amphotericin B and caspofungin resistance in Candida glabrata isolates recovered from a critically ill patient. Clin Infect Dis 2006, 42:938-944.
26. Pfaller MA, Messer SA, Bolmstrom A. Evaluation of Etest for determining in vitro susceptibility of yeast isolates to amphotericin B. Diagn Microbiol Infect Dis 1998, 32:223-227.
27. Warnock DW, Johnson EM, Rogers TR. Multi-centre evaluation of the Etest method for antifungal drug susceptibility testing of Candida spp. and Cryptococcus neoformans. BSAC working party on antifungal chemotherapy. J Antimicrob Chemother 1998, 42:321-331.
28. Dannaoui E, Abdul M, Arpin M. Results obtained with various antifungal susceptibility testing methods do not predict early clinical outcome in patients with cryptococcosis. Antimicrob Agents Chemother 2006, 50:2464-2470.
29. Dias AL, Matsumoto FE, Melhem MS. Comparative analysis of Etest and broth microdilution method (AFST-EUCAST) for trends in antifungal drug susceptibility testing of Brazilian Cryptococcus neoformans isolates. J Med Microbiol 2006, 55:1693-1699.
30. Baixench MT, Aoun N, Desnos-Ollivier M. Acquired resistance to echinocandins in Candida albicans: case report and review. J Antimicrob Chemother 2007, 59:1076-1083.